Metastatic Renal Cell Carcinoma Clinical Trials in San Francisco, California

3 studies are recruiting for metastatic renal cell carcinoma in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

    This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UCSF Medical Center-Mission Bay, San Francisco, California
    Locations
    328 in total
    Run by
    NRG Oncology

    See if you can join NCT05327686 on ClinicalTrials.gov

  2. Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

    This is a single-institution, phase 2 trial of zanzalintinib plus investigator-choice bone-strengthening agent in patients with metastatic renal cell carcinoma (RCC) with bone metastases whose disease has advanced on 1-3 prior lines of therapy, including at least one immune oncology-based (IO) ther…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    Kelly Fitzgerald, MD

    See if you can join NCT07043608 on ClinicalTrials.gov

  3. Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

    This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    California Pacific Medical Center-Pacific Campus, San Francisco, California
    Locations
    387 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT04510597 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.